المؤلفون: G. Bulava V., S. Rey I., G. Berdnikov A., O. Nikitina V., A. Shabanov K., N. Borovkova V., N. Salina N., M. Godkov A., Г. Булава В., С. Рей И., Г. Бердников А., О. Никитина В., А. Шабанов К., Н. Боровкова В., Н. Салина Н., М. Годков А.

المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 9, № 2 (2020); 201-209 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 9, № 2 (2020); 201-209 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2020-9-2

مصطلحات موضوعية: sepsis, septic shock, endotoxin lipopolysaccharide selective hemosorbtion, Polymyxin B hemoperfusion, LPS adsorber Alteco, extracorporeal hemocorrection, сепсис, септический шок, эндотоксин, селективная гемосорбция липополисахаридов, Полимиксин-В, гемоперфузия, ЛПС-адсорбер Альтеко, экстракорпоральная гемокоррекция

وصف الملف: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/929/766; https://www.jnmp.ru/jour/article/view/929/856; Rhee С, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 2017;318(13):1241–1249. PMID: 28903154 https://doi.org/10.1001/jama.2017.13836; Vincent JL, Lefrant JY, Kotfis K, Nanchal R, Martin-Loeches I, Wittebole X, et al. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP). Intensive Care Med. 2018;44(3):337–344. PMID: 29450593 https://doi.org/10.1007/s00134-017-5043-2; Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. PMID: 26903338 https://doi.org/10.1001/jama.2016.0287; Chen XH, Yin YJ, Zhang JX. Sepsis and immune response. World J Emerg Med. 2011;2(2):88–92. PMID: 25214990; Lewis DH, Chan DL, Pinheiro D, Armitage-Chan E, Garden OA. The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells. J Vet Intern Med. 2012;26:457–482. PMID: 22428780 https://doi.org/10.1111/j.1939-1676.2012.00905.x; Яковлев М.Ю. Кишечный липополисахарид: системная эндотоксинемия – эндотоксиновая агрессия – SIRS-полиорганная недостаточность как звенья одной цепи. Бюллетень ВНЦ СО РАМН. 2005;(1):15–18.; Triantafilou M, Triantafilou K. Sepsis: molecular mechanisms underlying lipopolysaccharide recognition. Expert Rev Mol Med. 2004;6(4):1–18. PMID: 14987416 https://doi.org/10.1017/S1462399404007409; Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, et al. Diagnostic and Prognostic Implications of Endotoxemia in Critical Illness: Results of the MEDIC Study. J Infect Dis. 2004;190(3):527–534. PMID: 15243928 https://doi.org/10.1086/422254; Reade MC, Huang DT, Bell D, Coats TJ, Cross AM, Moran JL, et al. Variability in management of early severe sepsis. Emerg. Med. J. 2010;27(2):110–115. PMID: 20156862 https://doi.org/10.1136/emj.2008.070912; Solomkin JS, Bauman MR, Neeson RD, Simmons RL. Neutrophils dysfunction during the course of intra-abdominal infection. Ann Surg. 1981;194(1):9–17. PMID: 7247540 https://doi.org/10.1097/00000658-198107000-00003; Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 2002;23(6):301– 304. PMID: 12072369; Cruz DN, Perazella MA, Dellomo R, de Cal M, Polanco N, Corradi V, еt al. Effectivnes of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007;11(2);R 47 PMID: 17448226 https://doi.org/10.1186/cc5780; Ikeda T, Ikeda K, Nagura M, Taniuchi H, Matsushita M, Kiuchi S, et al. Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure. Ther Apher Dial. 2004;8(4):293–298. PMID: 15274680 https://doi.org/10.1111/j.1526-0968.2004.00167.x; Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301(23):2445–2452. PMID: 19531784 https://doi.org/10.1001/jama.2009.856; Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41(6):975–984. PMID: 25862039 https://doi.org/10.1007/s00134-015-3751-z; Cutuli SL, Artigas A, Fumagalli R, Monti G, Ranieri VM, Ronco C, et al. EUPHAS 2 Collaborative Group. Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry. Ann Intensive Care. 2016;6(1):77. PMID: 27502196 https://doi.org/10.1186/s13613-016-0178-9; Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, et al. EUPHRATES Trial Investigators. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial. JAMA. 2018;320(14):1455–1463. PMID: 30304428 https://doi.org/10.1001/jama.2018.14618; Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44(12):2205–2212. PMID: 30470853 https://doi.org/10.1007/s00134-018-5463-7; Adamik B, Zielinski S, Smiechowicz J, Kübler A. Endotoxin Elimination in Patients with Septic Shock: An Observation Study. Arch Immunol Ther Exp (Warsz). 2015;63(6):475–483. PMID: 26093653 https://doi.org/10.1007/s00005-015-0348-8; Zagli G, Bonizzoli M, Spina R, Cianchi G, Pasquini A, Anichini V, et al. Effects of hemoperfusion with an immobilized polymixin-B fibers column on cytokine plasma levels in patients with abdominal sepsis.; Nakamura T, Ebihara I, Shimada N, Koide H. Changes in plasma erythropoietin and interkeukin-6 concentranions in patients with septic shock after hemoperfusion with polymixin B- immobilized fibers. Intensive Care Med. 1998;24(12):1272–1276. PMID: 9885879; Крстич М., Зулькарнаев А.Б. Селективная адсорбция эндотоксина в лечении гнойно-септических осложнений у пациентов с урологическими заболеваниями после трансплантации почки. Вестник трансплантологии и искусственных органов. 2014;16(1):21–28.; Yaroustovsky M, Plyushch M, Popov D, Samsonova N, Abramyan M, Popok Z, et al. Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery. J Inflamm (Lond). 2013;10(1):8. PMID: 23510603 https://doi.org/10.1186/1476-9255-10-8; Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Maeda S, Yamagishi S. Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients. J Crit Care. 2011;26(6):546–549. PMID: 21273029 https://doi.org/10.1016/j.jcrc.2010.11.010; Coudroy R, Payen D, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, et al. Modulation by Polymyxin-B Hemoperfusion of Inflammatory Response Related to Severe Peritonitis. Shock. 2017;47(1):93-99. PMID: 27984535 https://doi.org/10.1097/SHK.0000000000000725; https://www.jnmp.ru/jour/article/view/929

الاتاحة: https://www.jnmp.ru/jour/article/view/929
https://doi.org/10.23934/2223-9022-2020-9-2-201-209

المؤلفون: O. Nikitina V., I. Mikhailov P., N. Kudryashova Y., E. Migunova V., O. Alekseyechkina A., E. Kungurtsev V., N. Udalova M., S. Khusainov Z., I. Kostyuchenko B., О. Никитина В., И. Михайлов П., Н. Кудряшова Е., Е. Мигунова В., О. Алексеечкина А., Е. Кунгурцев В., Н. Удалова М., Ш. Хусаинов Ж., И. Костюченко Б.

المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 7, № 2 (2018); 134-143 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 7, № 2 (2018); 134-143 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2018-7-2

مصطلحات موضوعية: pulmonary embolism, thrombolytic therapy, anticoagulant therapy, perfusion scintigraphy, deficiency of pulmonary perfusion, pulmonary hypertension, тромбоэмболия легочной артерии, тромболитическя терапия, антикоагулянтная терапия, перфузионная сцинтиграфия, дефицит легочной перфузии, легочная гипертенз

وصف الملف: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/464/535; https://www.jnmp.ru/jour/article/view/464/536; Dong B., Pineo G., Mulrooney T. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst. Rev. 2002; (3): CD004437. DOI:10.1002/14651858.CD004437; Dong B.R., Yue J., Liu G.J., et al. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst. Rev. 2006; (2): CD004437. PMID: 16625603. DOI:10.1002/14651858.CD004437.pub2.; Dong B.R., Hao Q., Yue J., et al. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst. Rev. 2009; (3): CD004437. PMID: 19588357. DOI:10.1002/14651858.CD004437.pub3.; Hao Q., Dong B.R., Yue J., et al. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst. Rev. 2015; (9): CD004437. PMID: 26419832. DOI:10.1002/14651858.CD004437.pub4.; Meyer G., Vicaut E., Danays T., et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N. Engl. J. Med. 2014; 370(15): 1402–1411. PMID: 24716681. DOI:10.1056/NEJMoa1302097.; Cook G.J.R. Clinical Nuclear Medicine. London; New York, 2006. 915 p.; Konstantinides S.V., Torbicki A., Agnelli G., et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur. Heart J. 2014; 35(43): 3033-3069, 3069a-3069k. PMID: 25173341. DOI:10.1093/eurheartj/ehu283.; Torbicki A., Perrier A., Konstantinides S., et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2008; 29(18): 2276–2315. PMID: 18757870. DOI:10.1093/eurheartj/ehn310.; Pistolesi M., Lavorini F., Miniati M. Diagnostic strategies for suspected pulmonary embolism. European respiratory monograph. 2004. Monograph 30. Ch.6: Imaging: 89–105.; Van Beek E., Moody A.R., Oudkerk M. Imaging of pulmonary embolism: an overview. In: European respiratory monograph. 2003. Monograph 27. Ch.7: Pulmonary Vascular Pathology: A Clinical Update: 110–123.; Bajc M., Olsson B., Palmer J., et al. Ventilation / Perfusion SPECT for diagnostics of pulmonary embolism in clinical practice. J. Intern. Med. 2008; 264(4): 379–387. PMID: 18823506. DOI:10.1111/j.1365- 2796.2008.01980.x.; Collart J.P., Roelants V., Vanpee D., et al. Is a Lung perfusion scan obtained by using single photon emission computed tomography able to improve the radionuclide diagnosis of pulmonary embolism? Nucl. Med. Commun. 2002; 23(11): 1107–1113. PMID: 12411840. DOI:10.1097/01.mnm.0000040972.43128.16.; Corbus H.F., Seitz J.P., Larson R.K., et al. Diagnostic usefulness of lung SPECT in pulmonary thromboembolism: an outcome study. Nucl. Med. Commun. 1997; 18 (10): 897–906. PMID: 9392789.; Reinartz P., Wildberger J.E., Schaefer W., et al. Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT. J. Nucl. Med. 2004; 45(9): 1501–1508. PMID: 15347717.; Gutte H., Mortensen J., Jensen C.V., et al. Detection of pulmonary embolism with combined ventilation-perfusion SPECT and low-dose CT: head-to-head comparison with multidetector CT angiography. J. Nucl. Med. 2009; 50(12): 1987–1992. PMID: 19910421. DOI:10.2967/ jnumed.108.061606.; Савельев В.С., Яблоков Е.Г., Кириенко А.И. Массивная эмболия легочной артерии. М.: Медицина, 1990. 336 c.; Бокарев И.Н., Попова Л.В. Венозный тромбоэмболизм и тромбоэмболия легочной артерии. М.: МИА, 2005. 208 с.; https://www.jnmp.ru/jour/article/view/464

الاتاحة: https://www.jnmp.ru/jour/article/view/464
https://doi.org/10.23934/2223-9022-2018-7-2-134-143

المؤلفون: O. Nikitina V., I. Mikhailov P., N. Kudryashova Y., E. Migunova V., A. Dorfman G., V. Avfukov I., О. Никитина В., И. Михайлов П., Н. Кудряшова Е., Е. Мигунова В., А. Дорфман Г., В. Авфуков И.

المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 7, № 3 (2018); 209-216 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 7, № 3 (2018); 209-216 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2018-7-3

مصطلحات موضوعية: pulmonary embolism, thrombolytic therapy, anticoagulant therapy, perfusion scintigraphy, pulmonary perfusion deficiency, pulmonary hypertension, intermediate risk of early death, тромбоэмболия легочной артерии, тромболитическя терапия, антикоагулянтная терапия, перфузионная сцинтиграфия, дефицит легочной перфузии, легочная гипертензия, промежуточный риск ранней смерти

وصف الملف: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/501/562; https://www.jnmp.ru/jour/article/view/501/563; Савельев В.С., Чазов Е.И., Гусев Е.И., Кириенко А.И. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2010; (4, Вып. 2): 3–37.; Konstantinides S.V., Torbicki A., Agnelli G. et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur. Heart J. 2014; 35(43): 3033–3069, 3069a–3069k. PMID: 25173341. DOI:10.1093/eurheartj/ehu283.; Kearon C., Kahn S.R., Agnelli G., et al. American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6, Suppl.): 454S–545S. PMID: 18574272. DOI:10.1378/chest.08-0658.; Jaff M.R., McMurtry M.S., Archer S.L., et al. Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension A Scientific Statement From the American Heart Association. Circulation. 2011; 123(16): 1788–1830. PMID: 21422387. DOI:10.1161/CIR.0b013e318214914f.; British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax. 2003; 58(6): 470–484. PMID: 12775856.; Stein P.D., Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am. J. Med. 2012; 125(5): 465–470. PMID: 22325236. DOI:10.1016/j.amjmed.2011.10.015.; Meyer G., Vicaut E., Danays T., et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N. Engl. J. Med. 2014; 370(15): 1402–1411. PMID: 24716681. DOI:10.1056/NEJMoa1302097.; Konstantinides S.V., Barco S. Systemic Thrombolytic Therapy for Acute Pulmonary Embolism: Who Is a Candidate? Semin Respir Crit Care Med. 2017; 38(1): 56–65. PMID: 28208199. DOI:10.1055/s-0036-1597560.; Felgendreher R., Härtel D., Brockmeier J. et al. Acute pulmonary embolism: still a diagnostic and therapeutic challenge? Med Klin Intensivmed Notfmed. 2017; 112(6): 499–509. PMID: 27807613. DOI:10.1007/s00063-016-0221-5.; Konstantinides S.V., Barco S., Lankeit M., Meyer G. Management of Pulmonary Embolism: An Update. J Am Coll Cardiol. 2016; 67(8): 976–990. PMID: 26916489. DOI:10.1016/j.jacc.2015.11.061.; Marti C., John G., Konstantinides S. et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015; 36(10): 605–614. PMID: 24917641. DOI:10.1093/eurheartj/ehu218.; Meyer G., Planquette B., Sanchez O. Fibrinolysis for Acute Care of Pulmonary Embolism in the Intermediate Risk Patient. Curr Atheroscler Rep. 2015; 17(12): 68. PMID: 26486512. DOI:10.1007/s11883-0150546-1.; Marshall P.S., Tapson V., Jiménez D. Controversies in the Management of Life-Threatening Pulmonary Embolism. Semin Respir Crit Care Med. 2015; 36(6): 835–841. PMID: 26595043. DOI:10.1055/s-0035-1564733.; Sanchez O., Planquette B., Meyer G. Management of massive and submassive pulmonary embolism: focus on recent randomized trials. Curr Opin Pulm Med. 2014; 20(5): 393–399. PMID: 25029299. DOI:10.1097/MCP.0000000000000089.; Sharifi M., Bay C., Skrocki L. et al. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol. 2013; 111(2): 273–277. PMID: 2310288. DOI:10.1016/j.amjcard.2012.09.027.; Hao Q., Dong B.R., Yue J. et al. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst. Rev. 2015; (9): CD004437. PMID: 26419832. DOI:10.1002/14651858.CD004437.pub4.; Савельев В.С., Яблоков Е.Г., Кириенко А.И. Массивная эмболия легочной артерии. М.: Медицина, 1990. 336 с.; Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, New Jersey: Lawrence Erlbaum Associates, Publishers, 1988. 567 p.; https://www.jnmp.ru/jour/article/view/501

الاتاحة: https://www.jnmp.ru/jour/article/view/501
https://doi.org/10.23934/2223-9022-2018-7-3-209-216

المؤلفون: O. Nikitina V., I. Mikhailov P., D. Kosolapov A., V. Avfukov I., E. Ostrogina A., S. Kuznetsov N., T. Cherkashina N., N. Mirda I., О. Никитина В., И. Михайлов П., Д. Косолапов А., В. Авфуков И., Е. Острогина А., С. Кузнецов Н., Т. Черкашина Н., Н. Мирда И.

المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 7, № 1 (2018); 20-29 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 7, № 1 (2018); 20-29 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2018-7-1

مصطلحات موضوعية: pulmonary embolism, thrombolytic therapy, anticoagulant therapy, intermediate risk of adverse outcome, mortality rate, intracranial hemorrhages, cardiac arrhythmias, легочная эмболия, тромболитическая терапия, антикоагулянтная терапия, промежуточный риск неблагоприятного исхода, летальность, интракраниальные кровотечения, нарушения сердечного ритма

وصف الملف: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/433/496; https://www.jnmp.ru/jour/article/view/433/497; Савельев В.С., Чазов Е.И., Гусев Е.И., Кириенко А.И. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2010; 44(2–1): 3–37.; Konstantinides S.V., Torbicki A., Agnelli G., et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur. Heart J. 2014; 35(43): 3033–3069, 3069a–3069k. PMID: 25173341. DOI:10.1093/eurheartj/ehu283.; Kearon C., Kahn S.R., Agnelli G., et al. American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl): 454S–545S. PMID: 18574272. DOI:10.1378/chest.08-0658.; Jaff M.R., McMurtry M.S., Archer S.L., et al. Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension A Scientific Statement From the American Heart Association. Circulation. 2011; 123(16): 1788–1830. PMID: 21422387. DOI:10.1161/ CIR.0b013e318214914f.; British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58(6): 470–484. PMID: 12775856.; Torbicki A., Perrier A., Konstantinides S., et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008; 29(18): 2276–2315. PMID: 18757870. DOI:10.1093/eurheartj/ehn310.; Dong B., Pineo G., Mulrooney T. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst. Rev. 2002; (3). DOI:10.1002/14651858.CD004437.; Dong B.R., Yue J., Liu G.J., et al. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst. Rev. 2006 Apr 19; (2): CD004437. PMID: 16625603. DOI:10.1002/14651858.CD004437.pub2.; Dong B.R., Hao Q., Yue J., et al. Thrombolytic therapy for pulmonary embolism. . Cochrane Database Syst. Rev. 2009 Jul 8; (3): CD004437. PMID: 19588357. DOI:10.1002/14651858.CD004437.pub3.; Hao Q., Dong B.R., Yue J., et al. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst. Rev. 2015 Sep 30; (9): CD004437. PMID: 26419832. DOI:10.1002/14651858.CD004437.pub4.; Meyer G., Vicaut E., Danays T., et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N. Engl. J. Med. 2014; 370(15): 1402–1411. PMID: 24716681. DOI:10.1056/NEJMoa1302097.; Chatterjee S., Chakraborty A., Weinberg I., et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA. 2014; 311(23): 2414–2421. PMID: 24938564. DOI:10.1001/jama.2014.5990.; Stein P.D., Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med. 2012; 125(5): 465–470. PMID: 22325236. DOI:10.1016/j.amjmed.2011.10.015.; https://www.jnmp.ru/jour/article/view/433

الاتاحة: https://www.jnmp.ru/jour/article/view/433
https://doi.org/10.23934/2223-9022-2018-7-1-20-29

المؤلفون: G. Bulava V., M. Androsova V., A. Shabanov K., O. Nikitina V., I. Alexandrova V., Г. Булава В., М. Андросова В., А. Шабанов К., О. Никитина В., И. Александрова В.

المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 6, № 1 (2017); 13-19 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 6, № 1 (2017); 13-19 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2017-6-1

مصطلحات موضوعية: sepsis, predictors of sepsis, сепсис, маркеры — предикторы сепсиса

وصف الملف: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/338/406; Савельев В.С., Гельфанд Б.Р. (ред.) Сепсис: классификация, клинико-диагностическая концепция и лечение: практическое руководство. 3-е изд., доп. и пераб. М.: Медицинское информационное агентство, 2013. 360 с.; Lewis D.H., Chan D.L., Pinheiro D., et al. The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory antiinflammatory respons, and regulatory T сells. J. Vet. Intern. Med. 2012; 26(3): 457–482. PMID: 22428780 DOI:10.1111/j.1939-1676.2012.00905.x.; Antonelli M. Sepsis and septic shock: pro-inflammatory or antiinflammatory state? J. Chemother. 1999; 11(6): 536–540. PMID: 10678797 DOI:10.1179/joc.1999.11.6.536.; Cavaillon J.M., Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J. Endotoxin Res. 2006; 12(3): 151–170. PMID: 16719987 DOI:10.1179/096805106X102246.; Marshall J.C., Reinhart K. Biomarkers of sepsis. Crit. Care Med. 2009; 37(7): 2290–2298. PMID: 19487943 DOI:10.1097/CCM.0b013e3181a02afc.; Козлов В.К. Сепсис: этиология, иммунопатогенез, концепция современной иммунотерапии. СПб.: Диалект, 2006. 300 с.; Boomer J.S., To K., Chang K.C., et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011; 306(23): 2594–2605. PMID: 22187279 DOI:10.1001/jama.2011.1829.; Петров Р.В. Иммунология и иммуногенетика. М.: Медицина, 1976. 336 с.; Reinhart K., Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit. Care Clin. 2011; 27(2): 253–263. PMID: 21440200 DOI:10.1016/j.ccc.2011.01.002.; Hotchkiss R.S., Nicholson D.W. Apotosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 2006; 6(11): 813–822. PMID: 17039247 DOI:10.1038/nri1943.; Gaini S., Koldkjaer O.G., Pedersen C., Pedersen S.S. Procalcitonin, lipopolysac charide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit. Care. 2006; 10(2): R53. PMID: 16569262 DOI:10.1186/cc4866.; Heper Y., Akalin E.H., Mistik R., et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur. J. Clin. Microbiol. Infect. Dis. 2006; 25(8): 481–491. PMID: 16896829 DOI:10.1007/s10096-006-0168-1.; Lobo S.M., Lobo F.R., Bota D.P., et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003; 123(6): 2043–2049. PMID: 12796187.; Reinhart K., Bauer M., Riedemann N.C., Hartoga Ch.S. New approaches to sepsis: molecular diagnostics and biomarkers. Clin. Microbiol. Rev. 2012; 25(4): 609–634. PMID: 2303432 DOI:10.1128/CMR.00016-12.; Dandona P., Nix D., Wilson M.F., et al. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrin. Metab. 1994; 79(6): 1605–1608. PMID: 7989463 DOI:10.1210/jcem.79.6.7989463.; Вельков В.В. Прокальцитонин в диагностике критических состояний. Лабораторная медицина. 2009; (10): 49–54.; Maier M., Wutzler S., Lehnert M. et al. Serum procalcitonin levels in patients with multiple injuries including visceral trauma. J. Trauma. 2009; 66(1): 243–249. PMID: 19131834 DOI:10.1097/TA.0b013e31817c966f.; Шабанов А.К., Булава Г.В., Кислухина Е.В., Хубутия М.Ш. Критерии высокого риска развития инфекционных легочных осложнений при тяжелей сочетанной травме. Анестезиология и реаниматология. 2015; (2): 16–20.; Claeys R., Vinken S., Spapen H., et al. Plasma procalcitonin and Creactive protein in acuteseptic shock: clinical and biological correlates. Crit. Care Med. 2002; 30(4): 757–762. PMID: 11940741.; Villar J., Perez-Mundez L., Espinosa E., et al. Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis. PLoS One. 2009; 4(8): e6818. PMID: 19718443 DOI:10.1371/journal.pone.0006818.; Kellum J.A., Kong L., Fink M.P., et al. Understanding the inflammatory cytokine response in pneumonia and sepsis. Arch. Intern. Med. 2007; 167(15): 1655–1663. PMID: 17698689 DOI:10.1001/archinte.167.15.1655.; Giannoudis P.V., Hildebrand F., Pape H.C. Inflammatory serum markers in patients with multiple trauma. Can they predict outcome? J. Bone Joint Surg. Br. 2004; 86(3): 313–323. PMID: 15125116.; Гусев Е.Ю., Юрченко Л.Н., Черешнев В.А. и др. Варианты развития острого системного воспаления. Цитокины и воспаление. 2008; (2): 9–17.; Козлов В.К., Винницкий Л.И. Дисфункция иммунной системы в патогенезе сепсиса. Общая реаниматология. 2005; (4): 65–76.; Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6): 1644–1655. PMID: 1303622.; Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 2003; 31(4): 1250–1256. PMID: 12682500.; Kahlke V., Schafmayer C., Schniewind B., et al. Are postoperative complications genetically determined by TNF-β Ncol gene polymorphism? Surgery. 2004; 135(4): 365–373. PMID: 15041959 DOI:10.1016/j.surg.2003.08.012.; https://www.jnmp.ru/jour/article/view/338

الاتاحة: https://www.jnmp.ru/jour/article/view/338
https://doi.org/10.23934/2223-9022-2017-6-1-13-19